Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Unigrain is a leading industrial processor of oats and pulses based in Australia, with a significant focus on the development of high-value health and nutrition ingredients. The company utilizes advanced milling and extraction technologies to produce bioactive compounds, most notably oat beta-glucan, which is clinically recognized for its ability to lower cholesterol and manage blood glucose levels. Serving the global food, beverage, and nutraceutical industries, Unigrain bridges the gap between traditional agriculture and life sciences by providing science-backed functional ingredients. Their operations are centered on sustainable sourcing and rigorous quality standards, positioning them as a key supplier for health-focused consumer products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Unigrain.